Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Credit Rating
Reaffirmation of Credit Rating for long-term bank loan facilities26-06-2024
Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Credit Rating
Reaffirmation of Credit Rating for long-term bank loan facilitiesAarti Pharmalabs Ltd - 543748 - Closure of Trading Window
Intimation of Closure of Trading WindowAarti Pharmalabs Ltd - 543748 - Announcement Under Regulation 30 Of SEBI LODR, 2015
Closure of manufacturing activities at the Company''s Dombivli PlantAarti Pharmalabs Ltd - 543748 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the Financial Year ended March 31, 2024Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Q4 FY 24 Earnings Conference CallAarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Recording of the Earnings Conference Call for Q4 FY 24/ FY 24Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication of Audited Financial Results for the Quarter and Year ended March 31, 2024Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Investor Presentation
Q4 FY 24 /FY 24 Investor PresentationAarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Change in Directorate
Appointment of Smt. Nehal Garewal as Non-Executive Non-Independent Director of the Company